Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor
2024 · Nature Communications · 35 citations
https://doi.org/10.1038/s41467-024-45241-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
358
Citations
6
h-index
4
i10-index
Svenja M. Sake is an academic researcher from Center for Experimental and Clinical Infection Research. The author has contributed to research in topics: Respiratory viral infections research & Crystallization and Solubility Studies & X-ray Diffraction in Crystallography. The author has an h-index of 6, co-authored 12 publications.
Click to start Chat